We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+12.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.31B
AUM Growth
+$49.5M
Cap. Flow
-$34.5M
Cap. Flow %
-2.63%
Top 10 Hldgs %
65.03%
Holding
329
New
20
Increased
146
Reduced
123
Closed
37

Top Sells

Rank Stock Value
1
GRAB icon
Grab
GRAB
+$40.9M
2
NVDA icon
NVIDIA
NVDA
+$7.7M
3
MSFT icon
Microsoft
MSFT
+$6.02M
4
STAA icon
STAAR Surgical
STAA
+$5.62M
5
SE icon
Sea Limited
SE
+$3.76M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 45.37%
2 Technology 25.37%
3 Communication Services 8.93%
4 Healthcare 6.43%
5 Real Estate 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCVX icon
151
Vaxcyte
PCVX
$7.89B
$429K 0.03%
8,416
-418
-5% -$20.6K
KRYS icon
152
Krystal Biotech
KRYS
$9.88B
$428K 0.03%
3,687
+830
+29% +$101K
AEP icon
153
American Electric Power
AEP
$73.7B
$426K 0.03%
5,666
+961
+20% +$78.2K
GEHC icon
154
GE HealthCare
GEHC
$27.6B
$426K 0.03%
6,262
+901
+17% +$65.6K
BBIO icon
155
BridgeBio Pharma
BBIO
$16.5B
$424K 0.03%
16,095
-11,821
-42% -$335K
ROIV icon
156
Roivant Sciences
ROIV
$25.2B
$424K 0.03%
36,291
-2,434
-6% -$27.5K
ROST icon
157
Ross Stores
ROST
$76.6B
$423K 0.03%
3,749
+548
+17% +$62.9K
BEAM icon
158
Beam Therapeutics
BEAM
$2.58B
$420K 0.03%
17,470
+3,603
+26% +$96.6K
WDAY icon
159
Workday
WDAY
$33.4B
$420K 0.03%
1,953
+414
+27% +$96K
KRTX
160
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$420K 0.03%
2,482
+519
+26% +$97.6K
ANET icon
161
Arista Networks
ANET
$219B
$419K 0.03%
9,108
-656
-7% -$29.2K
APLS
162
DELISTED
Apellis Pharmaceuticals
APLS
$418K 0.03%
10,998
+6,035
+122% +$265K
CRSP icon
163
CRISPR Therapeutics
CRSP
$4.58B
$416K 0.03%
9,157
+1,863
+26% +$96.2K
EXC icon
164
Exelon
EXC
$48.6B
$414K 0.03%
10,944
+1,640
+18% +$66.8K
MSI icon
165
Motorola Solutions
MSI
$69.4B
$414K 0.03%
1,519
-120
-7% -$34.2K
ARWR icon
166
Arrowhead Research
ARWR
$12.1B
$411K 0.03%
15,293
+2,647
+21% +$81.1K
ALNY icon
167
Alnylam Pharmaceuticals
ALNY
$36.3B
$402K 0.03%
2,271
-70
-3% -$13.4K
EXAS
168
DELISTED
Exact Sciences
EXAS
$398K 0.03%
5,838
+751
+15% +$63.7K
DHR icon
169
Danaher
DHR
$135B
$396K 0.03%
1,799
+97
+6% +$21.6K
BKR icon
170
Baker Hughes
BKR
$56.8B
$392K 0.03%
11,107
+1,636
+17% +$57.9K
PRTA icon
171
Prothena Corp
PRTA
$458M
$389K 0.03%
8,059
+1,632
+25% +$97K
CEG icon
172
Constellation Energy
CEG
$98B
$386K 0.03%
3,537
+491
+16% +$50.6K
NTLA icon
173
Intellia Therapeutics
NTLA
$1.5B
$382K 0.03%
12,075
+1,745
+17% +$67.7K
PFE icon
174
Pfizer
PFE
$140B
$378K 0.03%
11,408
-421
-4% -$14.9K
VRSK icon
175
Verisk Analytics
VRSK
$26.4B
$377K 0.03%
1,596
+241
+18% +$56.8K

Similar funds

E Fund Management's Q3 2023 Portfolio in Review

As of Q3 2023, E Fund Management held 329 positions worth $1.31B, up 3.9% from $1.26B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

E Fund Management's Q3 2023 filing shows 20 new, 146 increased, 123 reduced and 37 closed positions. Its largest new stake was iShares MSCI Global Gold Miners ETF: 148,564 shares worth $3.08M. The largest sale was Grab, an estimated $40.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 45% of assets, up from 37% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q3 2023 buy was iShares MSCI Global Gold Miners ETF: 148,564 shares worth $3.08M.
  • E Fund Management added most to KLA in Q3 2023, an estimated $10.2M increase.
  • E Fund Management's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $7.7M.
  • E Fund Management fully exited Grab in Q3 2023, selling an estimated $40.9M.
  • E Fund Management's ten largest holdings make up 65% of its $1.31B portfolio in Q3 2023.
  • E Fund Management opened 20 new positions and closed 37 in Q3 2023.
  • E Fund Management's portfolio value rose 3.9% quarter-over-quarter to $1.31B.

Based on E Fund Management's 13F filing for Q3 2023, filed 13 Nov 2023.